Preserving continence in muscle-invasive bladder cancer

被引：0

作者：

Costello, Anthony ^{[1
]}

Goel, Rajiv ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Dept Urol, Melbourne, Vic 3050, Australia

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2009年 / 6卷 / 04期

关键词：

QUALITY-OF-LIFE; URINARY-DIVERSION; ILEAL NEOBLADDER; RADICAL CYSTECTOMY; COMPLICATIONS;

D O I：

10.1038/nrclinonc.2009.26

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Substantial progress has been made in radical cystectomy in the past 25 years, and development of orthotopic lower urinary tract reconstruction has been an important step in the continued progress of urinary diversion. The orthotopic neobladder should be considered the gold standard with which other forms of diversion are compared.

引用

页码：194 / 196

页数：4

共 50 条

[21] Management of muscle-invasive bladder cancer
Moon, Andrew
Van der Voet, Hans
Cresswell, Jo
TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (06) : 7 - 11
[22] Management of muscle-invasive bladder cancer
Mueller, J.
Schrader, A. J.
Schrader, M.
Schnoeller, T.
Jentzmik, F.
MINERVA UROLOGICA E NEFROLOGICA, 2013, 65 (04) : 235 - 248
[23] Chemotherapy for Muscle-Invasive Bladder Cancer
Trenta, Patrizia
Calabro, Fabio
Cerbone, Linda
Sternberg, Cora N.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
[24] Treatment of muscle-invasive bladder cancer
Sherif, Amir
Jonsson, Martin N.
Wiklund, N. Peter
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) : 1279 - 1283
[25] Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer
Onozawa, Mizuki
Miyanaga, Naoto
Hinotsu, Shiro
Miyazaki, Jun
Oikawa, Takehiro
Kimura, Tomokazu
Takaoka, Ei-ichiro
Kawai, Koji
Shimazui, Toru
Sakurai, Hideyuki
Nishiyama, Hiroyuki
Akaza, Hideyuki
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 825 - 830
[26] Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Konieczkowski, David J.
Efstathiou, Jason A.
Mouw, Kent W.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 567 - 584
[27] Current state of the art: Bladder-preserving trimodality therapy for muscle-invasive bladder cancer
Efstathiou, Jason A.
CLINICAL CANCER RESEARCH, 2024, 30 (10)
[28] Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer
Joung, Jae Young
Han, Kyung Seok
Kim, Taek Sang
Seo, Ho Kyung
Chung, Jinsoo
Lee, Kang Hyun
JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 598 - 603
[29] Bladder-preserving therapy for muscle-invasive bladder cancer: Should it be recommended to appropriate patients?
Hideyuki Akaza
Current Urology Reports, 2008, 9 (4) : 257 - 258
[30] Bladder sparing options for muscle-invasive bladder cancer
Laukhtina, Ekaterina
Moschini, Marco
Teoh, Jeremy Yuen-Chun
Shariat, Shahrokh F.
CURRENT OPINION IN UROLOGY, 2024, 34 (06) : 471 - 476

← 1 2 3 4 5 →